Copyright
©The Author(s) 2024.
World J Transplant. Sep 18, 2024; 14(3): 95905
Published online Sep 18, 2024. doi: 10.5500/wjt.v14.i3.95905
Published online Sep 18, 2024. doi: 10.5500/wjt.v14.i3.95905
Category | Examples |
Type of transplant | Combined kidney-pancreas |
Immunosuppressive medications | Cyclosporine |
Tacrolimus | |
Non-immunosuppressive medications | Angiotensin-converting enzyme inhibitors |
Angiotensin II receptor blockers | |
Beta-blockers | |
Steroidal mineralocorticoid antagonists (eplerenone, spironolactone) | |
Non-steroidal mineralocorticoid antagonists (finerenone) | |
Potassium-sparing diuretics (amiloride, triamterene) | |
Heparin | |
Mannitol | |
Non-steroidal anti-inflammatory drugs | |
Pneumocystis jirovecii pneumonia prophylactic agents (pentamidine, trimethoprim-sulfamethoxazole) | |
Succinylcholine | |
Others | Interstitial fibrosis and tubular atrophy |
Delayed graft function | |
Dietary indiscretion1 | |
Hyperglycemia | |
Metabolic acidosis | |
Type 4 renal tubular acidosis | |
Urinary tract obstruction |
- Citation: Aboghanem A, Prasad GVR. Disorders of potassium homeostasis after kidney transplantation. World J Transplant 2024; 14(3): 95905
- URL: https://www.wjgnet.com/2220-3230/full/v14/i3/95905.htm
- DOI: https://dx.doi.org/10.5500/wjt.v14.i3.95905